Unintentional Workplace Drug Overdose ( Name and Title of - - PowerPoint PPT Presentation

unintentional
SMART_READER_LITE
LIVE PREVIEW

Unintentional Workplace Drug Overdose ( Name and Title of - - PowerPoint PPT Presentation

24/7 Worker Safety Challenge Unintentional Workplace Drug Overdose ( Name and Title of Presenter) Overview The Opioid Crisis is a multifaceted problem with many dimensions. This training will focus on; How Organizations are Affected


slide-1
SLIDE 1

24/7 Worker Safety Challenge

( Name and Title of Presenter)

Unintentional Workplace Drug Overdose

slide-2
SLIDE 2

Overview

▪ The Opioid Crisis is a multifaceted problem with many dimensions. This training will focus on; – How Organizations are Affected – Local Concerns – What are Opioids – Overdose Prevention – What Resources are available

slide-3
SLIDE 3

Why?

  • Occupational fatalities in 1970 were about 14,000

workers

  • Industry still has the same hazards as 1970

– Struck by, caught in, electrical and falls

  • The “goal” at that time was
  • Zero Accidents and everyone goes home safe at

night

slide-4
SLIDE 4

Today’s Workplace?

Occupational fatalities in 2017 were about 5,147 workers

  • Slip, trip and fall / 887
  • Struck by object / 695
  • Electrical contact / 154
  • Transportation accidents / 2,077
  • Death by Suicide / 275
  • Unintentional Overdoses / 272

https://www.bls.gov/iif/oshcfoi1.htm#2017

slide-5
SLIDE 5

New workplace Challenge is 24/7

– Don’t just ensure your workers go home safe –Every American worker should return home safely, and also arrive healthy at the start of the next shift.

  • Suicide Prevention
  • Opioid Crisis
  • PTSD

– Organizations still have moral obligation to employees even if not a legal one

slide-6
SLIDE 6

Nationwide

▪ Opioid misuse and overdose deaths from opioids are serious health issues in the United States. ▪ Overdose deaths involving prescription and illicit

  • pioids doubled from 2010 to 2016, with more than

42,000 deaths in 2016 (CDC) ▪ 49,000 opioid overdose deaths in 2017 (CDC) ▪ October 2017, the President declared the opioid

  • verdose epidemic to be a public health emergency.
slide-7
SLIDE 7

Workplace Unintentional Overdose Prevention

▪ The rate of fatal opioid-related overdose was higher among workers employed in industries and

  • ccupations known to have high rates of work-related

injuries and illnesses. ▪ Consistent with previous research documenting common use of prescribed opioids for management of acute and chronic pain following work-related injury. ▪ The rate was also higher among workers in

  • ccupations with lower availability of paid sick leave

and lower job security.

slide-8
SLIDE 8

Local concerns

(Slides 8-15 are Massachusetts specific but can be replaced with other states information if needed.)

slide-9
SLIDE 9

Massachusetts

▪ There were a total of 5,580 opioid-related overdose deaths in Massachusetts from 2011 through 2015. ▪ 4,302 deaths with usable industry and/or occupation information for inclusion in the analysis.

– Those excluded due to missing industry and occupation information were similar to those in the final study group with respect to gender, and age, but were less likely to be white, non-Hispanic. This missing information may have resulted in underestimates of rates for racial/ethnic groups

  • ther than white, non-Hispanic.
slide-10
SLIDE 10

Local need and response

slide-11
SLIDE 11

All Deaths by Industry - Massachusetts

▪ Workers in five industry sectors had opioid-related

  • verdose death rates (per 100,000 workers) that

were significantly higher than the average rate for all workers (25.1):

– Construction (124.9) – Agriculture, forestry, fishing and hunting (107.5)2 – Transportation and warehousing (48.3) – Administrative and support and waste management services (43.1)3 – Accommodation and food services (36.5)

slide-12
SLIDE 12

All Deaths by Industry- Massachusetts

slide-13
SLIDE 13

All Deaths by Construction Industry- Massachusetts

slide-14
SLIDE 14

Stigma and People Who Use Drugs

▪ Often experience social rejection, labeling, stereotyping and discrimination. ▪ Manifests in a variety of ways, including denial of employment

  • r housing, social isolation, estrangement from family and

friends, and incarceration. ▪ Less likely to be offered help than are people with a mental illness or physical disability. ▪ Healthcare professionals often hold negative, stereotyped views of people who use drugs. ▪ Stigma is a major factor preventing individuals from seeking and completing addiction treatment and from utilizing harm reduction services

slide-15
SLIDE 15

What Can Be Done to Fight Stigma?

▪ Many people who use drugs do not experience negative consequences, develop physical dependence, or develop a substance use disorder. However, some people do. A substance use disorder is a chronic health condition with risks and

  • consequences. People with substance use disorders

should be afforded the same dignity, respect and support as someone with any other chronic health condition.

slide-16
SLIDE 16

Words Matter

slide-17
SLIDE 17

What are Opioids?

Opioids are either derived from the opium poppy or are synthetically

  • manufactured. Whether

synthetic or naturally

  • ccurring, opioids all act

in similar ways at specific sites in the body. In the peripheral tissues,

  • pioids reduce pain by

blocking pain receptors.

slide-18
SLIDE 18

Opioids differ in both strength and length of action.

▪ 1. Opioids come in short-acting and long-acting formulations

– Oral methadone, a slow-acting opioid, has its peak effect at 4-6 hours and can stay in the body for more than 24 hours.

▪ 2. Changing how an opioid is formulated can turn a long- acting, less potent medication, into a more potent, rapid acting

  • ne.

– If an extended release tablet is crushed and snorted or injected, the medication can become short-acting and more potent.

▪ 3. Changing how an opioid is administered can make an

  • pioid faster acting and more potent.
slide-19
SLIDE 19

Mike’s Rx Awareness Story

https://www.youtube.com/watch?v=-oHUNpHzIA0#action=share

slide-20
SLIDE 20

Overdose Prevention: How and When to Administer Nasal Narcan

Video Boston Public Health

https://www.youtube.com/watch?v=DGn-1ktzhpA&feature=youtu.be

slide-21
SLIDE 21

(Skip to Slide 39)

▪ After viewing video

slide-22
SLIDE 22

Fentanyl

▪ Synthetic opioid administered intravenously in hospital settings for anesthesia, rapid pain control, and as an infusion to maintain sedation among patients managed in intensive care. ▪ 2013, illicitly-made fentanyl started showing up regularly in the heroin supply in New England to increase the potency and decrease the cost of the street heroin supply. ▪ Fentanyl sold as heroin, counterfeit prescription opioids, and as cocaine, has been responsible for a surge in

  • pioid-related deaths in Massachusetts since 2013, due

to both the potency and rapid acting of the drug.

slide-23
SLIDE 23

What is an opioid overdose?

Opioids in high doses can cause respiratory depression and death. This is because of the effect of

  • pioids on the part of the brain which regulates

breathing.

▪ The symptoms of an opioid overdose include: – Unresponsiveness to verbal or physical stimulation – Respiratory depression (no or slow breathing) – Blue lips and fingertips ▪ Other symptoms that may be present in an overdose include: – Slow heartbeat or pulse – Deep snoring or gurgling (aka the death rattle) – Pinpoint pupils

slide-24
SLIDE 24

What is Naloxone?

▪ Naloxone is the antidote to an opioid

  • verdose.

– blocks the opioid from attaching on to the receptors in the brain. – Temporarily reverses the opioid effects, giving the person a chance to breathe. – Typically works in about 3 minutes and lasts for 30-90 minutes.

slide-25
SLIDE 25

What is Naloxone?

▪ Naloxone cannot cause an overdose. However, administering too much naloxone can cause withdrawal symptoms such as: – Anxiety, runny nose and eyes, chills – muscle discomfort, disorientation, combativeness – nausea/vomiting – diarrhea – cravings for opioids

slide-26
SLIDE 26

Several forms of Naloxone

slide-27
SLIDE 27

How People Respond to Naloxone

▪ • Most people start breathing again in 3-5 minutes

– Some require more doses, especially with fentanyl – Naloxone kits usually include at least two doses • – Most often people feel confused, embarrassed, anxious, etc. – The goal of using naloxone is to get people breathing again, not necessarily to wake them up right away or to take away the person’s high

▪ Rushing to wake a person up by giving several naloxone doses can cause withdrawal ▪ Reassure survivors that withdrawal symptoms will diminish as the naloxone wears off

slide-28
SLIDE 28

Preventing Overdose: Knowing Overdose Risk Factors

▪ Opioid Dose and Changes in Purity ▪ In 2018, assume that all street drugs contain fentanyl.

– Fentanyl is a potent, rapid-acting opioid that can be lethal in very small amounts. – A bag of heroin, for instance, can vary greatly in

  • purity. Drug sellers may enhance the strength of weak

heroin by cutting it with fentanyl or other psychoactive

  • substances. It is common for street drugs sold as

heroin to contain no heroin, and fentanyl is the only

  • pioid.
slide-29
SLIDE 29

Preventing Overdose: Knowing Overdose Risk Factors

▪ Previous Near Fatal Overdose ▪ Experiencing an overdose increases the risk

  • f dying from an overdose in the future.

– People who have previously overdosed may have drug use patterns that continue to put them at risk for an overdose in the future. – May also have a “genetic predisposition” to

  • verdose, which means that the genes they were

born with may not protect them from overdose as well as other people’s genes.

slide-30
SLIDE 30

Preventing Overdose: Knowing Overdose Risk Factors

▪ Risk of Overdose increases after a period of abstinence such as: – Incarceration – Hospitalization – Detoxification or other types of drug-free treatment – Section 35 Commitment

slide-31
SLIDE 31

Preventing Overdose: Knowing Overdose Risk Factors

▪ Mixing Opioids with other substances / polypharmacy

– All sedating medications carry overdose risks of their own; however, when drugs are combined, the risk is substantially increased. The sedating effects of the drugs work together making the sedation greater for these drugs used in combination than it would have been if any of the drugs were used alone.

slide-32
SLIDE 32

How to Respond to an Overdose

slide-33
SLIDE 33

How to Respond to an Overdose

slide-34
SLIDE 34

How to Respond to an Overdose

slide-35
SLIDE 35

How to Respond to an Overdose

Stimulation: Sternal Rub

– If a person is not responding and you suspect an overdose, try to wake them up – Call name and shake the person. If this doesn’t work, rub your knuckles into the sternum (the breastbone in middle of chest) – You can also rub your knuckles

  • n their upper lip

– Tell them you are going to administer naloxone and continue to explain out-loud the steps you are taking in the response

slide-36
SLIDE 36

How to Respond to an Overdose

If a person does not respond to stimulation, call 9-1-1! ▪ Call 9-1-1 whether person responds to naloxone or not ▪ Person overdosing may have

  • ther medical issues

▪ Person can overdose again

  • nce naloxone wears off
slide-37
SLIDE 37

How to Respond to an Overdose

Good Samaritan Law:

▪ The Massachusetts Good Samaritan Law encourages friends, family, and/or bystanders to assist people having an

  • verdose and to seek emergency

medical assistance. The law has significant potential to help reduce the impact of the opioid epidemic and save lives.

slide-38
SLIDE 38

How to Respond to an Overdose

STAY UNTIL HELP ARRIVES ▪ If you must leave the scene of an overdose for whatever reason, ensure that the person who overdosed is in the recovery position and easily accessible by first responders.

slide-39
SLIDE 39

Fatal Overdoses and Experiencing Loss

▪ Every individual who is exposed to a fatality has their own personal history and current experiences related to loss, trauma, and stress as well as their own style of coping, level of resilience, and capacity for healing, all of which will influence each person’s reaction to the death.

slide-40
SLIDE 40

Reference Documents

▪ Massachusetts Department of Public Health Overdose Education and Naloxone Distribution Program Core Competencies – http://www.mass.gov/naloxone ▪ Opioid-related Overdose Deaths in Massachusetts by Industry and Occupation, 2011-2015 – https://www.mass.gov/files/documents/2018/08/07/opioid-industry-occupation.pdf – http://www.bphc.org/whatwedo/Recovery-Services/prevention/Pages/Narcan- Program.aspx ▪ CDC/NIOSH Naloxone Fact Sheet – https://www.cdc.gov/niosh/docs/2019-101/pdfs/2019-101- 508.pdf?id=10.26616/NIOSHPUB2019101

slide-41
SLIDE 41

Resources Available

https://findtreatment.samhsa.gov/

slide-42
SLIDE 42

https://findtreatment.samhsa.gov/

Resources Available

slide-43
SLIDE 43

https://dpt2.samhsa.gov/treatment/

Resources Available

slide-44
SLIDE 44

Summary

▪ This training is modeled after the MDPH Overdose Education and Naloxone Distribution Program as part of a comprehensive strategy that includes overdose prevention and response. ▪ Included in OEND document are links and videos that provide support for these prevention and response strategies. ▪ This discussion is limited to the core competencies that are expected of participants in the MDPH Overdose Education and Naloxone Distribution Program.

slide-45
SLIDE 45

Survey Questions The link is now active and can be found at https://www.surveymonkey.com/r/MTKC97R

slide-46
SLIDE 46

Survey Questions The link is now active and can be found at https://www.surveymonkey.com/r/MTKC97R

slide-47
SLIDE 47